Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant Laparoscopic Inguinal or Umbilical Herniorrhaphy
Status:
Completed
Trial end date:
2011-06-20
Target enrollment:
Participant gender:
Summary
This study will assess pain intensity for the first 72 hrs after aggravated movement (cough)
following Laparoscopic Inguinal or Umbilical Herniorrhaphy.